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Abstract
HLA-G plays a role in fetal-maternal tolerance as well as immunoregulation, and has been
suggested to be involved in autoimmune diseases and cancers. HLA-G encodes two poten-
tially functional polymorphisms in the 3’ untranslated region, 14bp insertion/deletion (14bp
indel, rs371194629) and a single nucleotide polymorphism rs1063320, previously reported
to affect HLA-G expression level or splicing isoform and to be associated with susceptibility
to systemic lupus erythematosus (SLE). However, the results of SLE association studies
are inconsistent, probably due to the small sample size of each study and lack of consider-
ation of linkage disequilibrium (LD) with HLA-class II haplotypes in each population. In this
study, we performed association studies of these polymorphisms on 843 patients with SLE
and 778 healthy controls in a Japanese population, in many of whom HLA-DRB1 alleles
have been genotyped at the four-digit level. LD was detected between DRB1*13:02,
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protective against multiple autoimmune diseases in the Japanese, and the rs1063320 G (D’
= 0.86, r2 = 0.02) and with 14bp del (D’ = 0.62, r2 = 0.01), but not between SLE-susceptible
DRB1*15:01 and HLA-G. Although significant association with overall SLE was not
detected, 14bp ins allele was significantly associated with SLE with the age of onset <20
years, when compared with healthy controls (P = 0.0067, PFDR = 0.039, OR 1.44, additive
model) or with SLE patients with the age of onset20 (P = 0.033, PFDR = 0.0495, OR 2.09,
additive model). This association remained significant after conditioning on DRB1*13:02 or
DRB1*15:01. On the other hand, significant association was detected between rs1063320
C and anti-RNP antibody and anti-Sm antibody positive SLE, which was dependent on neg-
ative LD with DRB1*13:02. eQTL analysis showed reduced HLA-GmRNA level in 14bp ins/
ins individuals. In conclusion, our observations showed that HLA-G 14bp ins allele repre-
sents a genetic contribution on early-onset SLE independent of DRB1.
Introduction
Systemic lupus erythematosus (SLE) is a prototype of systemic autoimmune diseases, caused
by a combination of multiple genetic and environmental factors. Epidemiological studies
showed higher prevalence in African American, Hispanic, and Asian rather than Caucasian
populations [1]. Moreover, a number of twin studies convincingly demonstrated the evidence
for the genetic component in SLE [2]. To date, more than 70 susceptibility regions were identi-
fied by genome-wide association studies (GWAS) as well as candidate gene studies [3].
The strongest association is localized in the major histocompatibility complex (MHC)
region at 6p21.3 [4, 5]. Association of HLA-DRB115:01 and DRB103:01 haplotypes has been
established in Caucasian and East Asian populations [6–9]. However, due to the extensive and
long-range linkage disequilibrium (LD) encompassing not only HLA genes but also potentially
relevant non-HLA genes, the search for the causative allele is still underway.
HLA-G, encoded near the telomeric end ofMHC region, is one of the non-classical class I
molecules. Although the role for HLA-G in fetal-maternal tolerance in placenta is well recog-
nized, HLA-G is also physiologically expressed in the thymus, pancreas, lung, erythroid, mac-
rophage, and endothelial precursors. Expression of HLA-G is induced under conditions such
as inflammation and viral infection, and plays a role in immunoregulation [10, 11].
HLA-G interacts with immune inhibitory receptors expressed on NK cells, T cells, mono-
cytes, and dendritic cells (DCs), such as leukocyte immunoglobulin-like receptor (LILR) B1,
LILRB2, and killer cell immunoglobulin-like receptor (KIR) 2DL4 [11]. Previous studies have
shown that HLA-G inhibited activation of CD8+ T cells and NK cells, proliferation of CD4+ T
cells, differentiation of antigen presenting cells and B cells, and induced regulatory T cells and
IL-10 producing DCs [10].
Unlike classical HLA, HLA-G gene has limited polymorphisms in its coding region; how-
ever, seven splicing isoforms including those generating soluble HLA-G (sHLA-G) as well as
polymorphisms in the regulatory regions are known [12]. Among the latter, 14bp insertion
polymorphism (14bp indel) (rs371194629) and a single nucleotide polymorphism (SNP),
rs1063320 (G>C) in 3’ untranslated region (UTR), have been suggested to have functional sig-
nificance. The 14bp insertion allele (ins) has been shown to be associated with alternative splic-
ing and to result in deletion of 92 bp in exon 5 from mature mRNA, which then leads to low
levels of soluble HLA-G (sHLA-G) [13]. Although some evidence also suggested that 14bp ins
allele generated more stable mRNA than 14bp deletion (del) allele [14], most studies
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demonstrated significantly lower sHLA-G levels in individuals with 14bp ins/ins genotype [15,
16]. The association of 14bp indel with susceptibility to various diseases has been reported
[10]. With respect to SLE, significant increase of 14bp ins allele was observed in a study from
Italy [17], and although other studies in South American [18–21] and Asian [22] populations
did not reach statistical significance, many of them showed a trend toward increase in 14bp ins
allele frequency and/or association with clinical subsets, and meta-analyses reported significant
association with susceptibility to SLE [21, 23, 24].
On the other hand, the SNP rs1063320 G>C is located at microRNA (miRNA) (miR-148a,
miR-148b, miR-152) binding site. It was demonstrated that the G allele of rs1063320 increases
the affinity of interaction with these miRNA and results in the reduction of HLA-G expression
[25]. With respect to disease associations, significant increase of G allele has been reported in
asthma [25] and in SLE [18, 19].
Interestingly, although located ~2.8 Mb apart, linkage disequilibrium was reported between
some combinations of HLA-DRB1 andHLA-G alleles [12, 26, 27]. For example, DRB103:01
haplotype strongly associated with risk of SLE in the Caucasian populations is in LD with
HLA-G 14bp ins allele [28].
Thus, several studies with limited sample size suggested association of HLA-G 3’UTR poly-
morphisms with SLE. However, most of the studies did not consider LD withHLA-class II SLE
risk or protective haplotypes. Only Fernando et al. has taken LD into account, and demon-
strated an independent genetic contribution ofHLA-G region in a Filipino population [6].
However, they did not address the relationship between the marker and HLA-G 3’UTR 14bp
indel nor rs1063320.
Association study of HLA-G with SLE in a Japanese population has not been reported. In
view of the unique genetic background of the Japanese population where the allele frequency of
DRB103:01 is exceptionally low (0.1%) even among the East Asian populations [29], it was of
interest to examine the association between HLA-G 3’UTR polymorphisms and SLE. In the
present study, we carried out a case-control association study to examine the association
between HLA-G and SLE, among many of whom DRB1 alleles were already genotyped at the
“four-digit” level (high resolution) [8]. We detected LD between SLE-protective DRB113:02
and the rs1063320 G and with 14bp del, but not between SLE-susceptible DRB115:01. HLA-G
14bp ins allele was increased in SLE, especially those with the age of onset<20 years. This asso-
ciation remained significant when conditioned on DRB115:01 and DRB113:02. These results
suggested an independent role of HLA-G 14bp ins in the development of SLE in the patients
with early age of onset.
Subjects and Methods
Subjects
Genomic DNA from 843 Japanese SLE patients and 778 healthy controls recruited at the uni-
versities and rheumatology centers were examined. All patients were classified as SLE accord-
ing to the American College of Rheumatology classification criteria for SLE [30]. Presence or
absence of nephropathy was classified according the same criteria [30]. Early-onset was defined
as an age of onset of earlier than 20 years of age. The clinical characteristics of the patients are
shown in Table 1.
All healthy controls were unrelated Japanese, among whom 578 were recruited at the
research institutes in the Kanto area, where most of the patients were also recruited. In addi-
tion, genomic DNA from 200 healthy controls were derived from the B cell lines deposited by
Japan Biological Informatics Consortium and purchased from the Health Science Research
Resources Bank.
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Ethics statement
This study was reviewed and approved by the Ethics Committees of the following institutes:
University of Tsukuba Faculty of Medicine, Sagamihara Hospital, National Hospital Organiza-
tion, Juntendo University School of Medicine, Yokohama Minami Kyosai Hospital, Yokohama
City University Medical Center, Tokyo Metropolitan Cancer and Infectious Diseases Center
Komagome Hospital, Kitasato University School of Medicine, Tokyo Metropolitan Tama Med-
ical Center, Himeji Medical Center, National Hospital Organization, Morioka Hospital,
National Hospital Organization, Kyushu Medical Center, National Hospital Organization,
Nagoya Medical Center, National Hospital Organization, and Teikyo University School of
Medicine.
Written informed consent was obtained from all participants, except for some individuals
who donated the blood for the purpose of medical genetics study before 2001, prior to the
enforcement of the Ethics Guidelines for Human Genome/Gene Analysis Research by the Japa-
nese government. From such individuals, oral informed consent for the genetics study had
been obtained. In accordance with the Japanese Ethical Guidelines for Human Genome/Gene
Analysis Research, such samples were anonymized in an unlinkable fashion, and were included
in this study, after review and approval by the Ethics Committee of University of Tsukuba.
This study was conducted according to the principles expressed in the Declaration of Helsinki.
Genotyping for 14bp indel
Genotype ofHLA-G 14bp indel was determined by multiplex PCR as previously described
[13]. The sequence of the primers and probes used in this study are shown in S1 Table. Ampli-
Taq Gold1 360 Master Mix (Applied Biosystems) 5 μL was used in 10 μL reaction mixture
containing 0.1 μM of each primer. The PCR conditions consisted of initial denaturation at
95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 64°C for
60 s, and extension at 72°C for 30 s. The PCR products were detected by 7.5% acrylamide gel
electrophoresis and staining using SYBR1 Gold nucleic acid gel stain (Life technologies)
(Fig 1).
Genotyping for HLA-G rs1063320
TaqMan SNP genotyping assay (ABI 7300, Applied Biosystems) was used to determine the
genotype of rs1063320. Custom-designed TaqMan probes were purchased (S1 Table). For
PCR, DNA samples (10–50 ng/μL) were added to the reaction mixture containing TaqMan1
Table 1. Patients and healthy controls examined in this study.
Subjects n %*
all SLE 843
age of onset <20 144 18.6%
nephropathy (+) 397 49.6%
anti-dsDNA Ab (+) 654 82.4%
anti-Sm Ab (+) 252 32.5%
anti-RNP Ab (+) 254 40.4%
HC 778
*Proportion of the patients of each subcategory among those with available data. Ab: antibody, HC: healthy
controls.
doi:10.1371/journal.pone.0158065.t001
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Genotyping Master Mix (Applied Biosystems) and TaqMan probes. The PCR conditions con-
sisted of initial denaturation at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C
for 15 s, annealing at 60°C for 60 s.
Expression quantitative trait loci (eQTL) analysis
Association between HLA-G 14bp indel genotype and mRNA level ofHLA-G was examined as
follows. Genotypes of the HapMap JPT subjects for the 14bp indel were obtained from the
1000 Genomes project database (http://browser.1000genomes.org/index.html). The mRNA
expression levels of HLA-G in the B lymphoblastoid cell lines from the same subjects were
retrieved from GeneVar database (http://www.sanger.ac.uk/science/programmes) [31]. The
probe GI_24797072 was placed within the 3’UTR and detect all isoforms ofHLA-G. The differ-
ence in the mRNA levels between the genotypes was examined using regression analysis under
the recessive model of 14bp ins allele.
Statistical analysis
Association analysis was performed by logistic regression analysis under the additive model
using R software (https://journal.r-project.org). First, “all SLE” group and each clinical subset
were compared with healthy controls (case-control analysis). Next, the subsets which showed
significant association in the case-control analysis were compared with the patients negative
for the clinical characteristics (case-case analysis). P values for the case-control analysis and
case-case analysis of overall SLE as well as each clinical subset at the two polymorphic sites
(Tables 2–5, altogether 15 comparisons) were adjusted for false discovery rate (FDR) using the
graphically sharpened method [32, 33]. FDR-adjusted P (PFDR)<0.05 was considered signifi-
cant. Odds ratio (OR) was calculated for 14bp ins allele and rs1063320 C allele. Power calcula-
tion using Quanto program (http://biostats.usc.edu/Quanto.html) was conducted based on
logistic regression analysis (S2 Table).
Association of the 14bp indel genotype with the age of onset of SLE was examined using
regression analysis.
Conditional logistic regression analysis was used to evaluate contribution of each polymor-
phism among the polymorphisms in potential LD.
Calculation for LD coefficient D’ and r2, estimation of haplotype frequencies, and permuta-
tion test were performed using HaploView software [34]. Permutation for 100,000 times was
conducted for haplotype analysis.
Fig 1. Genotyping forHLA-G 14 indel polymorphism. (Left) Primers were placed to encompass the 14bp indel site between primers. (Right)
Polyacrylamide gel electrophoresis of the PCR products. The upper band in the ins/del lane shows the heteroduplex product formed by the ins and del allele
products, which takes altered conformation and shows retardation in electrophoretic mobility. Ins, insertion; del, non-insertion.
doi:10.1371/journal.pone.0158065.g001
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Table 2. Case-control analysis of 14bp indel polymorphismwith SLE and its clinical subsets.
n genotype (%) allele (%) additive model
ins/ins ins/del del/del Ins P PFDR OR (95%CI)
all SLE 843 56 (6.6) 351(41.6) 436(51.7) 463(27.5) 0.12 1.13 (0.97–1.33)
age of onset <20 144 17(11.8) 61(42.4) 66(45.8) 95(33.0) 0.0067 0.039 1.44 (1.10–1.87)
nephropathy (+) 397 25(6.3) 169(42.6) 203(51.1) 219(27.6) 0.19 1.14 (0.94–1.38)
anti-dsDNA Ab (+) 654 50(7.6) 264(40.4) 340(52.0) 364(27.8) 0.096 1.15 (0.98–1.36)
anti-Sm Ab (+) 252 17(6.7) 105(41.7) 130(51.6) 139(27.6) 0.26 1.14 (0.91–1.42)
anti-RNP Ab (+) 254 18(7.1) 97(38.2) 139(54.7) 133(26.2) 0.61 1.06 (0.85–1.32)
HC 777 58(7.5) 273(35.1) 446(57.4) 389(25.0) ref
Logistic regression analysis was used to test the association of 14bp indel under the additive model. Ins: insertion, del: non-insertion, OR: odds ratio, CI:
conﬁdence interval, ref: referent, Ab: antibody, HC: healthy controls.
doi:10.1371/journal.pone.0158065.t002
Table 3. Case-case analysis on the association of 14bp ins polymorphismwith early age of onset of SLE.
n genotype (%) allele (%) additive model
ins/ins ins/del del/del ins P PFDR OR (95%CI)
age of onset <20 144 17(11.8) 61(42.4) 66(45.8) 95 (33.0) 0.033 0.0495 1.36 (1.02–1.80)
age of onset 20 632 38 (6.0) 263 (41.6) 331(52.4) 339 (26.8) ref
Logistic regression analysis was performed to compare the 14bp indel genotypes between SLE patients with the age of onset <20 and 20 years. OR:
odds ratio, CI: conﬁdence interval.
doi:10.1371/journal.pone.0158065.t003
Table 4. Case-control analysis of rs1063320 with SLE and its clinical subsets.
n genotype (%) allele (%) additive model
G/G G/C C/C C P PFDR OR (95%CI)
all SLE 843 408(48.4) 349(41.4) 86(10.2) 521(30.9) 0.096 1.14 (0.98–1.32)
age of onset <20 144 76(52.8) 58(40.3) 10(6.9) 78(27.1) 0.69 0.94 (0.71–1.25)
nephropathy (+) 397 189(47.6) 169(42.6) 39(9.8) 247(31.1) 0.14 1.15 (0.95–1.39)
anti-dsDNA Ab (+) 654 328(50.2) 257(39.3) 69(10.6) 395(30.2) 0.25 1.10 (0.94–1.29)
anti-Sm Ab (+) 252 116(46.0) 102(40.5) 34(13.5) 170(33.7) 0.020 0.040 1.29 (1.04–1.60)
anti-RNP Ab (+) 254 114(44.9) 107(42.1) 33(13.0) 173(34.1) 0.013 0.039 1.31 (1.06–1.62)
HC 778 399(51.3) 319(41.0) 60(7.7) 439(28.2) ref
OR was calculated for the C allele. HC: healthy controls, OR: odds ratio, CI: conﬁdence interval, ref: referent, Ab: antibody.
doi:10.1371/journal.pone.0158065.t004
Table 5. Case-case analysis on the association of rs1063320 with anti-Sm and anti-RNP antibody-positive SLE and antibody-negative SLE.
n genotype (%) allele (%) additive model
G/G G/C C/C C P OR (95%CI)
anti-Sm Ab (+) SLE 252 116(46.0) 102(40.5) 34(13.5) 170(33.7) 0.082 1.22 (0.97–1.52)
anti-Sm Ab (-) SLE 523 265(50.7) 210(40.2) 48(9.2) 206(29.3) ref
anti-RNP Ab (+) SLE 254 114(44.9) 107(42.1) 33(13.0) 173(34.1) 0.15 1.19 (0.94–1.51)
anti-RNP Ab (-) SLE 374 185(49.5) 153(40.9) 36(9.6) 225(30.1) ref
Logistic regression analysis was performed to compare the rs1063320 genotypes between SLE patients positive (+) and negative (-) for anti-Sm and anti-
RNP antibodies (Ab). OR: odds ratio, CI: conﬁdence interval, ref, referent.
doi:10.1371/journal.pone.0158065.t005
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Results
Association study of HLA-G 14bp indel
Genotype frequency of 14bp indel in the healthy controls was not significantly departed from
Hardy-Weinberg equilibrium (P = 0.075). Significant association was not observed in overall
SLE. When the clinical subsets of SLE were analyzed, significant association of 14bp ins allele
was observed in early-onset (age<20) SLE both in case-control analysis (P = 0.0067, PFDR =
0.039, OR 1.44, 95%CI 1.10–1.87) (Table 2) and in case-case analysis (P = 0.033, PFDR =
0.0495, OR 1.36, 95%CI 1.02–1.80) (Table 3). Association of 14bp indel was also observed with
actual age of onset of each patient by regression analysis under the recessive model of the ins
allele (β = -4.54, 95%CI -8.55 –-0.52, P = 0.027).
Association study of rs1063320 with SLE
Genotype frequency in the healthy controls were not significantly departed from Hardy-Wein-
berg equilibrium (P = 0.73). The C allele of the SNP rs1063320 showed significant increase in
the SLE patients positive for anti-Sm antibody (P = 0.020, PFDR = 0.040, OR 1.29, 95%CI 1.04–
1.60) and in those positive for anti-RNP antibody P = 0.013, PFDR = 0.039, OR 1.31, 95%CI
1.06–1.62) when compared with healthy controls (Table 4).
In the case-case analysis between the antibody positive and negative patients, the association
did not reach statistical significance, although the tendency for stronger association was
observed in the antibody positive subsets (Table 5).
Analysis of independent contribution of HLA-G from HLA-DRB1
Because DRB115:01 and DRB113:02 are associated with risk and protection of SLE, respec-
tively, we performed conditional logistic regression analysis to investigate the independent
contribution of HLA-G from DRB1 alleles on 827 patients and 576 healthy controls in whom
we already genotyped DRB1 alleles [8]. DRB1 allele frequencies of the patients and healthy con-
trols as well as the results of association analysis are shown in S3 Table.
LD plots between DRB115:01, DRB113:02 andHLA-G 3’UTR polymorphisms in our
healthy controls are shown in Fig 2. LD was detected between SLE-protective DRB113:02 and
HLA-G 14bp del (D’ = 0.62, r2 = 0.01) and, more strongly, rs1063320 G (D’ = 0.86, r2 = 0.02).
On the other hand, only weak LD was observed between SLE-susceptible DRB115:01 and
HLA-G 14 bp ins (D’ = 0.03, r2 = 0.00) and rs1063320 C (D’ = 0.16, r2 = 0.00). Negative LD was
observed between HLA-G 14 bp ins and rs1063320 C (D’ = -0.90, r2 = 0.11).
The association between HLA-G 14bp ins and early-onset SLE remained significant when
conditioned on DRB115:01 and DRB113:02, both in the case-control analysis and case-case
analysis (Table 6). On the other hand, the association of rs1063320 with anti-Sm antibody and
anti-RNP antibody positive SLE lost significance when conditioned on DRB113:02 (Table 6).
In contrast, the association of DRB115:01 and DRB113:02 was unaffected when condi-
tioned on HLA-G alleles (S4 Table).
These results implied thatHLA-G 14bp ins allele has an independent contribution for early-
onset SLE, while the association of rs1063320 C with anti-Sm and anti-RNP production is
dependent on LD between the protective DRB113:02 and rs1063320 G allele.
Association study of the haplotypes formed byHLA-G and DRB1. We next estimated
the haplotype frequencies formed by HLA-G alleles and DRB113:02 (Table 7). Four haplo-
types with haplotype frequencies >1% were estimated using HaploView [34]. DRB113:02 was
present only on theHLA-G 14bp del-rs1063320 G haplotype. Significant protection against
overall SLE was observed for 14bp del-rs1063320 G haplotype carrying DRB113:02, but not
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Fig 2. Linkage disequilibrium parameters betweenHLA-G 14bp indel, rs1063320 andDRB1*15:01 orDRB1*13:02. LD was detected between
DRB1*13:02 andHLA-G 14bp del and, more strongly, rs1063320 G. Only weak LD was observed between DRB1*15:01 andHLA-G alleles. Negative LD
was observed between HLA-G 14 bp ins and rs1063320 C (shown in blue matrix in the LD plot).
doi:10.1371/journal.pone.0158065.g002
Table 6. Conditional logistic regression analysis to evaluate contribution ofHLA-G genotypes when conditioned onHLA-DRB1*15:01 and
DRB1*13:02.
Conditioned on:
none DRB1*15:01 DRB1*13:02
P OR (95%CI) P OR (95%CI) P OR (95%CI)
14bp ins
age of onset <20 vs HC 0.0067 1.44 (1.10–1.87) 0.032 1.36 (1.02–1.80) 0.044 1.33 (1.01–1.76)
age of onset <20 vs 20 0.033 1.36 (1.02–1.80) 0.046 1.34 (1.00–1.77) 0.049 1.33 (1.00–1.77)
rs1063320 C
anti-Sm Ab (+) vs HC 0.020 1.29 (1.04–1.60) 0.062 1.24 (0.99–1.56) 0.16 1.18 (0.94–1.48)
anti-RNP Ab (+) vs HC 0.013 1.31 (1.06–1.62) 0.072 1.23 (0.98–1.55) 0.15 1.18 (0.94–1.49)
Conditional logistic regression analysis demonstrated independent contribution of HLA-G 14bp ins on the age of onset of SLE, but the association of
rs1063320 C on the production of anti-Sm and anti-RNP antibodies was dependent on LD with DRB1 alleles. OR was calculated for the ins or C allele.
OR: odds ratio, CI: conﬁdence interval, ref: referent, Ab: antibody, HC: healthy controls.
doi:10.1371/journal.pone.0158065.t006
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for the sameHLA-G haplotype carrying other DRB1 alleles, suggesting that the protective effect
against overall SLE is mediated by DRB113:02 rather than HLA-G. Similarly, protection
against anti-Sm or anti-RNP antibody positive SLE was observed only for the haplotype carry-
ing DRB113:02.
In contrast, 14bp ins was present essentially on the haplotypes not carrying DRB113:02.
Among such haplotypes, only those carrying 14bp ins demonstrated significant increase in
early-onset SLE, suggesting that 14bp ins itself is responsible for, or tags the functional variant
associated with, early-onset of SLE.
eQTL analysis of HLA-G 14bp indel.
To elucidate the effect ofHLA-G 14bp indel on the mRNA expression, eQTL analysis was per-
formed using the genotype data of the HapMap JPT samples andHLA-GmRNA levels in the B
lymphoblastoid cell lines derived from the same subjects. As shown in Fig 3,HLA-GmRNA
level was significantly lower in individuals with 14bp ins/ins genotype (β = -0.338, 95%CI
-0.672 –-0.005, P = 0.047).
Discussion
In the present study, we conducted an association study of twoHLA-G 3’UTR polymorphisms,
previously suggested to have functional significance, with SLE for the first time in a Japanese
population. Our sample size was probably the largest among the HLA-G association studies
with SLE. In addition, we took advantage of our previous study in which we genotyped SLE
patients and healthy controls for theHLA-DRB1 allele at the high resolution (“four-digit”)
level [8], and tested for the independent association of HLA-G. We detected association of
HLA-G 3’UTR 14bp ins (rs371194629) with SLE, and rs1063320 C with anti-RNP and anti-Sm
antibody positive SLE. SLE-protective HLA-DRB113:02 allele was found to be in LD with
HLA-G 14 bp del and rs1063320 G (Fig 2). Thus, the obvious question is whether the increase
ofHLA-G 14 bp and rs1063320 C may be secondarily caused by the decrease of DRB113:02.
In the case of HLA-G 14bp ins, three findings support the “independent” contribution of
HLA-G 14 bp.
First, HLA-G 14bp ins was significantly associated with SLE with the age of onset<20 even
after conditioning on DRB113:02 status (Table 6). Next, increase of HLA-G 14 bp ins was
observed not only when compared with healthy controls, but also in the case-case analysis
which compared SLE patients with the age of onset<20 and 20 years, while DRB113:02 did
not show significant association in the case-case analysis (S4 Table). Finally, in the haplotype
Table 7. Estimation of haplotype frequencies constituted byHLA-G 14bp indel, rs1063320 andDRB1*13:02 and association analysis.
haplotype estimated haplotype frequency (%) Ppermutation vs HC
14bp rs1063320 DRB1 all SLE early-
onset
anti-Sm Ab
(+)
anti-RNP
Ab (+)
HC all SLE early-
onset
anti-Sm Ab
(+)
anti-RNP
Ab (+)
del G other 38.6 37.4 39.9 40.1 39.1 0.99 0.96 1.0 1.0
del C other 30.5 26.8 27.3 26.3 27.3 0.17 1.0 1.0 0.98
ins G other 26.7 32.0 28.0 27.7 24.3 0.38 0.020 0.12 0.17
del G 13:02 3.3 2.9 3.8 4.3 7.6 1.0 x 10−5 0.011 0.0089 0.038
Haplotype estimation and association analysis was conducted by permutation test using HaploView. 100,000 times permutation was conducted. The
haplotypes with frequencies more than 1% are shown. Independent effect of HLA-G 14bp ins-G haplotype from DRB1*13:02 was supported by this
analysis. Early-onset: SLE with the age of onset <20; Ab: antibody, HC: healthy controls.
doi:10.1371/journal.pone.0158065.t007
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analysis, only the haplotype with HLA-G 14 bp ins was increased among the three haplotypes
which do not carry DRB113:02 (Table 7).
In contrast, association of rs1063320 C with anti-RNP antibody or anti-Sm antibody posi-
tive SLE lost significance when conditioned on DRB113:02 (Table 6). Thus, we concluded that
the association of this SNP was caused by negative LD with DRB113:02.
Association ofHLA-G 3’UTR polymorphisms with SLE has been reported with inconsistent
results [6, 15–21]. Although HLA-class II and HLA-G genes are located at the opposite ends of
theMHC region and are 2.8 Mb distant from each other, several studies reported LD between
them [12, 26–28, 35]. With respect toHLA-G association studies with SLE, only one has con-
sidered LD withHLA-class II haplotypes [6]. It is likely that difference in the LD between
Fig 3. DecreasedHLA-GmRNA level in 14bp ins/ins genotype.HLA-GmRNA levels in the B lymphoblastoid cell lines
were compared between HapMap JPT individuals with 14bp del/del or ins/del genotypes and ins/ins genotype using
regression analysis. Significant decrease was detected in individuals with ins/ins genotype β = -0.338, 95%CI -0.672
–-0.005, P = 0.047). The number of the subjects in each group is shown in the parentheses.
doi:10.1371/journal.pone.0158065.g003
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HLA-class II andHLA-Gmight be related to the inconsistencies among the results of the previ-
ous association studies.
DRB113:02 is carried by a long-range extended haplotype A33:03-C14:03-B44:03-
DRB113:02-DQB106:04-DPB104:01, which shows evidence for positive selection in the Japa-
nese population [29]. This haplotype was reported to be present in Korean populations, but
may not be present in other Asian populations [29]. Among our subjects, 172 healthy controls
had been genotyped for HLA-A. LD between A33:03 and HLA-G rs1063320 G (D’ = 1, r2 =
0.051) and also between A33:03 and HLA-G14bp del (D’ = 1, r2 = 0.043) were detected. Simi-
larly, all other HLA alleles on the extended haplotype are expected to be in LD. Thus, to untan-
gle contribution of each allele in LD, allele typing of all the classical HLA-class I and class II
alleles should eventually be carried out in all the patients and controls, which is beyond the
scope of this study. Thus, at this point, it would be reasonable to conclude that HLA-G 14bp
ins represents a genetic contribution on early-onset SLE independent of DRB1.
In our study, the association of 14bp ins with early-onset SLE remained significant after
conditioning on DRB113:02 and DRB115:01 alleles. Although 14bp ins has been shown to be
in strong LD with DRB103:01 [28, 35], the major risk allele for SLE in the Caucasian popula-
tions, DRB103:01 is very rare in the Japanese population (allele frequency 0.1% [29]), and can-
not explain the association of 14bp ins. Thus, the Japanese population provided a unique
opportunity to distinguish the association ofHLA-G 14bp and DRB103:01. On the other
hand, the association of DRB115:01 remained strong after conditioning on 14bp ins. Thus, it
is considered that DRB115:01 and HLA-G 14bp ins, or other alleles in strong LD with them,
have independent genetic contribution for susceptibility to SLE.
HLA-G 14bp ins was not found to be associated with specific clinical symptoms, but associa-
tion was mainly observed in the patients with early age of onset<20 years. The association was
also significant when compared with those with the age of onset20 years in case-case analysis
(Table 3), and regression analysis among the patients. This is probably because the SLE patients
with younger onset are associated with higher genetic risk [36] and susceptibility alleles were
more sensitively detectable in such patients.
Although statistically not significant, the genotype distribution in the healthy controls
showed slight tendency toward deviation from Hardy-Weinberg equilibrium (P = 0.075).
Although we could not find other association studies of 14bp indel in the Japanese population
in the literature, we were able to retrieve small population data from the 1000 Genomes
Browser (http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/): ins/ins 6 (5.8%), ins/
del 40 (38.5%), del/del 58 (55.8%). When this control set is used instead of our healthy subjects,
the association of early-onset SLE barely missed significance level (P = 0.059) due to the small
sample size of the controls; however, the OR was 1.47 (95%CI 0.99–2.19), and was slightly
higher than the OR observed with our controls (1.44, Table 2). Thus, we think that the detected
association was not merely caused by the slight tendency toward deviation from Hardy-Wein-
berg equilibrium of the healthy control genotype frequencies.
Although previous reports demonstrated association of HLA-G 14bp indel with SLE and
various autoimmune diseases including celiac disease, pemphigus vulgaris and multiple sclero-
sis, the genetic association as well as its functional consequences are not yet established [10,
11]. Most studies demonstrated decreased sHLA-G level in individuals with the14bp ins/ins
genotype [15, 16], although conflicting results are reported [14]. By combining the sequencing
data of the HapMap subjects from the 1000 genomes project database and the expression data
from the GeneVar database, we confirmed the low HLA-GmRNA level in individuals with
14bp ins/ins genotype (Fig 3).
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HLA-G has seven mRNA isoforms generated by alternative splicing, among which three
code for sHLA-G. sHLA-G is present as monomers or dimers, and each can be present in β2-
microglobulin associated and unassociated forms, potentially having different conformation
and affinity with various monoclonal antibodies. This makes it difficult to accurately quantitate
both membrane-bound HLA-G and sHLA-G protein. Genotyping of genomic polymorphisms
may possibly offer more stable and technically undemanding biomarker as compared with
detection of membrane-bound or sHLA-G at the protein level.
HLA-G has been shown to be involved in inhibition of NK cells, neutrophils, dendritic cells,
T cells and B cells via LILRB1 and LILRB2 (reviewed in [11]). Thus, lower level of sHLA-G
may account for the excessive activation observed in multiple immune cell types in SLE. Of
interest, deletion polymorphism encompassing the large part of LILRA3, a soluble receptor
which possibly antagonizes binding of sHLA-G and LILRB1/LILRB2, has been associated with
a variety of immune system disorders [37]. A recent study reported association of LILRA3
non-deletion allele encoding functional LILRA3 molecule with susceptibility to SLE [38]. This
observation is in line with the idea that decreased inhibitory signal from sHLA-G may be asso-
ciated with the development of SLE. Genetic interaction between LILR andHLA-G genotypes
involved in the occurrence of autoimmune diseases will be an intriguing subject of study in the
future.
Although association between HLA-G 14bp ins with SLE has previously been reported, con-
ditional analysis for the independent association as well as the association with early-onset SLE
need to be replicated in future studies.
In conclusion, this study demonstrated association of HLA-G 14bp ins allele with early-
onset SLE in the Japanese population. This association was independent from the association
of DRB115:01 with the risk and DRB113:02 with the protection of SLE. Further studies will
be necessary to establish the extendedMHC haplotype dependent and independent roles of
HLA-G polymorphisms.
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